PIK3CA mutation, but not PTEN loss of function, determines the sensitivity of breast cancer cells to mTOR inhibitory drugs
Year: 2011
Type: article
Source: Oncogene
DOI: 10.1038/onc.2011.42
Authors: B Weigelt, P H Warne, J Downward
Institution: Cancer Research UK
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2012346684
